Chronic Obstructive Pulmonary Disease and the frequent hospital readmissions : Can anything be done?

Authors

  • G. S. Gaude Department of Pulmonary Medicine, J. N. Medical College, Belgaum -590010, INDIA
  • J. Hattiholi Department of Pulmonary Medicine, J. N. Medical College, Belgaum -590010, INDIA
  • A. Chaudhury Department of Pulmonary Medicine, J. N. Medical College, Belgaum -590010, INDIA

Keywords:

COPD, Acute exacerbation, Hospitalization, Heart failure, Mortality

Abstract

Acute exacerbations of COPD (AECOPD) are known to be associated with increased morbidity and mortality and have a significant socioeconomic impact. The factors that determine frequent hospital readmissions for AECOPD are poorly understood. The aim of this study was to ascertain the factors responsible for the repeated admissions for AECOPD. We conducted a prospective study of 235 patients with COPD with one or more admissions for acute exacerbations in a tertiary care hospital. Frequency of previous readmissions for AECOPD in the past year, and clinical characteristics, including spirometry were ascertained in the stable state both before discharge and at 6-month post discharge. All the patients were followed up for a period of two years after discharge to evaluate the readmissions for the acute exacerbations. Among 149 COPD patients who were admitted and assessed for AECOPD, there were 278 readmissions for AECOPD over a follow-up period of 24 months. Of these, 27% had one readmission, while rest 78% had two or more readmissions during this period. There was a high prevalence of current or ex-heavy smokers, associated co-morbidity, underweight patients and low prevalence of vaccination and use of domiciliary oxygen therapy among COPD patients. A total of 15.4% mortality was observed in the present study. The multivariate logistic regression analysis for repeated admissions revealed that disease duration >10 years (OR =0.50; 95% CI: 0.27 -0.93), non-use of inhaled corticosteroids (ICS +LABA) (OR = 2.31; 95% CI: 2.26–4.88), lower serum albumin level (<2gm/dl) (OR = 0.48; 95% CI: 0.26–0.88), MRC dyspnea grade > 3 (OR = 1.15; 95% CI: 2.56–4.89), body mass index (BMI) <20 (OR =0.62, 95% CI: 0.31-1.23) and non-use of Tiotropium (OR = 1.21, 95% CI: 0.67-2.19) were independently associated with frequent readmissions for AECOPD. The repeated exacerbations in COPD were common with major burden to the society. The major factors influencing frequency of repeated COPD exacerbations were disease duration, non-prescription of inhaled corticosteroids (ICS +LABA) and Tiotropium, lower serum albumin level (<2gm/dl), lower BMI and MRC dyspnea grade > 3.

References

Rabe, K.F., Hurd, S., Anzueto, A., 2007. Global Initiative for Chronic Obstructive Lung Disease, et al. Global strategy

for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive

summary. Am. J. Respir. Crit. Care. Med., 176, 532-555.

Houlguin, F., Folch, E., Redd, S.C., et al., 2005. Mannino DM. Comorbidity and mortality in COPD-related

hospitalizations in the United States, 1979 to 2001. Chest., 128, 2005-2011.

Mnanino, D.M., Buist, A.S., 2007. Global burden of COPD: risk factors, prevalence, and future trends. Lancet, 370,

-773.

Connors, A.F., Dawson, N.V., Thomas, C., et al., 1996. Outcomes following acute exacerbation of severe chronic

obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for

Outcomes and Risks of Treatments). Am. J. Respir. Crit. Care. Med., 154, 959–67.

National Institutes of Health., 2002. National Heart, Lung and Blood Institute. Morbidity and Mortality: 2002 Chart

Book on Cardiovascular, Lung and Blood Diseases. May 2002. [Cited 5 September 2003] Available from URL:

http://www.nhlbi.nih.gov (accessed on October 12th, 2013).

Garcia-Aymerich, J., Farrero, E., Félez, M.A., et al., 2003. Risk factors of re-admission to hospital for a COPD

exacerbation: a prospective study. Thorax, 58, 100–5.

Pouw, E.M., Ten Velde, G.P., Croonen, B.H., at al., 2000. Kester AD, Schols AH, Wouters EF. Early non-elective readmission for chronic obstructive pulmonary disease is associated with weight loss. Clin. Nutr., 19, 95–99.

Rodriguez-Roisin, R., Anzueto, A., Bourbeau, J., at al., 2010. Global Initiative for Chronic Obstructive Lung Disease.

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease:

GOLD executive summary (Updated 2010), pp 1-117.

Groenewegen, K.H., Schols, A.M., Wouters, E.F., 2003. Mortality and mortality-related factors after hospitalization

for acute exacerbation of COPD. Chest., 124, 459-467.

Bahadori, K., FitzGerald, J.M., Levy, R.D., at al., 2009. Risk factors and outcomes associated with chronic obstructive

pulmonary disease exacerbations requiring hospitalization. Can. Respir. J., 16(4), e43-e49.

Wang, Q., Bourbeau, J., 2005. Outcomes and health-related quality of life following hospitalization for an acute

exacerbation of COPD. Respirol., 10, 334-340.

Celli, B.R., 1997. Is pulmonary rehabilitation an effective treatment for chronic obstructive pulmonary disease? Yes.

Am. J. Respir. Crit. Care. Med., 155, 781–3.

Nichols, K.L., Baken, L., Nelson, A., 1999. Relation between influenza vaccination and outpatient visits,

hospitalization, and mortality in elderly persons with chronic lung disease. Ann. Intern. Med., 130, 397–403.

Vestbo, J., Prescott, E., Lange, P., et al., 1998. Vital prognosis after hospitalization for COPD: a study of a random

population sample. Respir. Med., 92, 772–776.

Advisory Committee on Immunization Practices (ACIP)., 1998. Prevention and control of influenza:

recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly

Rep., 47, 1–26.

Kesseler, R., Faller, M., Weitzenblum, E., et al., 2001. Natural history of pulmonary hypertension in a series of 131

patients with chronic obstructive lung disease. Am. J. Respir. Crit. Care. Med., 164, 219-224.

McGhan, R., Radcliff, T., Fish, R., et al., 2009. Predictors of rehospitalization and death after a severe exacerbation

of COPD. Lung, 187, 128-135.

Abusaid, G.H., Barbagelata, A., Tuero, E., et al., 2009. Diastolic dysfunction and COPD exacerbation. Postgrad.

Med., 121, 76-81.

Douglas, S.L., Daly, B.J., Gordon, N., et al., 2002. Survival and quality of life: short-term versus long-term ventilator

patients. Crit. Care. Med., 30, 2655–62.

Baker, E.H., Janaway, C.H., Philips, B.J., et al., 2006. Hyperglecemia is associated with poor outcomes in patients

admitted to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax., 61, 284-289.

Garcia-Aymerich J, Barreiro E, Farrero E et al (2000). Patients hospitalized for COPD have a high prevalence of

modifiable risk factors for exacerbation (EFRAM study). Eur. Respir. J., 16: 1037–1042.

Horn, S.D., Sharkey, P.D., Buckle, J.M., et al., 1991. The relationship between severity of illness and hospital length

of stay and mortality. Med. Care., 29, 305-317.

Skyba, P., Kluchova, Z., Joppa, P., et al., 2009. Nutritional status in relation to respiratory impairment and systemic

inflammation in patients with acute exacerbation of COPD. Med. Sci. Mon., 15, CR528-CR533.

Tsimogianni, A.M., Papiris, S.A., Stathopoulos, G.T., et al., 2009. Predictors of outcome after exacerbation of

chronic obstructive pulmonary disease. J. Gen. Intern. Med., 24, 1043-1048.

Emerman, C.L., Effron, D., Lukens, T.W., 1991. Spirometric criteria for hospital admission of patients with acute

exacerbation of COPD. Chest., 99, 595-599.

Seemungal, T.A., Donaldson, G.C., Paul, E.A., et al., 1998. Effect of exacerbation on quality of life in patients with

chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care. Med., 157(5 Pt 1), 1418-1422.

Dusser, D., Bravo, M-L., Iacono, P., 2006. The effect of tiotropium on exacerbations and airflow in patients with

COPD. Eur. Respir. J., 27, 547–555.

McGhan, R., Radcliff, T., Fish, R., et al., 2007. Predictors of rehospitalization and death after a severe exacerbation

of COPD. Chest., 132,1748-1755.

Tashkin, D.P., Celli, B., Senn, S., et al., 2008. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

N. Engl. J. Med., 359, 1543–1554.

Calverley, P.M.A., Anderson, J.A., Celli, B., et al., 2007. Salmeterol and fluticasone propionate and survival in

chronic obstructive pulmonary disease. N. Engl. J. Med., 2007, 356, 775–789.

Soler-Catalufia, J.J., Martinez-Garcia, M.A., Roman Sanchez, E., et al., 2005. Severe acute exacerbations and

mortality in patients with chronic obstructive pulmonary disease. Thorax., 60, 925-931.

Fruchter, O., Yigla, M., 2008. Predictors of long-term survival in elderly patients hospitalized for acute

exacerbations of chronic obstructive pulmonary disease. Respirol., 13, 851-855.

Wang, Q., Bourbeau, J., 2005. Outcomes and health-related quality of life following hospitalization for an acute

exacerbation of COPD. Respirol., 10, 334–340.

Published

2013-12-28

How to Cite

S. Gaude, G., Hattiholi, J. ., & Chaudhury, A. . (2013). Chronic Obstructive Pulmonary Disease and the frequent hospital readmissions : Can anything be done?. Scientific Journal of Medical Science, 2(12), 242-251. Retrieved from http://sjournals.com/index.php/sjms/article/view/1303

Issue

Section

Original Article